735 related articles for article (PubMed ID: 19272490)
21. Calcium antagonists in antihypertensive combination therapy.
Hansson L; Himmelmann A
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S76-80. PubMed ID: 1725010
[TBL] [Abstract][Full Text] [Related]
22. A comparison of four primary classes of antihypertensive monotherapy in Thai patients.
Sukonthasarn A
J Med Assoc Thai; 2000 Oct; 83(10):1202-10. PubMed ID: 11143486
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
Waeber B
Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
[TBL] [Abstract][Full Text] [Related]
24. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
25. Systolic hypertension.
Nash DT
Geriatrics; 2006 Dec; 61(12):22-8. PubMed ID: 17184139
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
[TBL] [Abstract][Full Text] [Related]
27. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Weir MR
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
29. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
Naderi SH; Bestwick JP; Wald DS
Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
[TBL] [Abstract][Full Text] [Related]
30. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
31. Effects of antihypertensive drugs on blood pressure and proteinuria in childhood.
Simonetti GD; Rizzi M; Donadini R; Bianchetti MG
J Hypertens; 2007 Dec; 25(12):2370-6. PubMed ID: 17984655
[TBL] [Abstract][Full Text] [Related]
32. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
33. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
Mizuno Y; Jacob RF; Mason RP
Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
[TBL] [Abstract][Full Text] [Related]
34. [Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ace inhibitors and calcium channel blockers?].
Eliseev OM
Ter Arkh; 2011; 83(5):70-5. PubMed ID: 21780662
[TBL] [Abstract][Full Text] [Related]
35. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
36. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure and coronary heart disease: a review of the evidence.
Lawes CM; Bennett DA; Lewington S; Rodgers A
Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
[TBL] [Abstract][Full Text] [Related]
38. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
[TBL] [Abstract][Full Text] [Related]
40. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1129-1138. PubMed ID: 32675281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
